# Kyverna Therapeutics, Inc.: Form 8-K, filed Nov 12, 2025

- Company: [Kyverna Therapeutics, Inc.](/companies/kytx.md) (CIK 1994702)
- Form: 8-K
- Filed: 2025-11-12
- Accepted by EDGAR: Nov 12, 2025, 16:09 ET
- Period: 2025-11-12
- Accession: 0001193125-25-277569
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1994702/000119312525277569/kytx-20251112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1994702/000119312525277569/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1994702/000119312525277569/kytx-20251112.htm

Filed Nov 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-277569. Last ingested by Listed: Nov 12, 2026, 18:10 ET. No prices; not investment advice.